DNAJB4: A promising drug target and biomarker for human liver diseases

Target Name: DNAJB4

NCBI ID: G11080

DNAJB4

DNAJB4: A promising drug target and biomarker for human liver diseases

Introduction

The liver is a vital organ that plays a critical role in the body, responsible for filtering waste products, producing bile, and maintaining the body's chemical balance. Unfortunately, liver diseases, including various types of cancer, are a leading cause of morbidity and mortality worldwide. Therefore, identifying and targeting potential drug targets and biomarkers for these diseases is of great importance. One of the promising targets for liver diseases is DNAJB4, a protein that is expressed in high levels in human liver tissue.

DNAJB4 function and localization

DNAJB4 is a member of the DNAJB family, which includes several related proteins that are involved in various cellular processes, including DNA replication, transcription, and repair. DNAJB4 is a 24.5 kDa protein that is predominantly expressed in the liver, with lower levels found in other tissues such as muscle and heart. The liver is the only tissue that expresses DNAJB4 at high levels, which suggests that it plays an important role in the liver's function.

DNAJB4 is localized to the liver endoplasmic reticulum (ER), which is the protein synthesis and modification site for proteins that export to the ER. The ER is a transmembrane system that separates the cytoplasm from the ER membrane, and it plays a crucial role in regulating the delivery of proteins to the cytoplasm. The localization of DNAJB4 to the ER is consistent with its role in the regulation of protein synthesis and delivery, and suggests that it may be a useful drug target for liver diseases.

DNAJB4 as a drug target

DNAJB4 has been identified as a potential drug target for a variety of liver diseases due to its unique localization to the ER. Several studies have demonstrated that inhibiting DNAJB4 activity can lead to the downregulation of various proteins that are involved in liver disease, including those associated with Proteins associated with tumor development.

For example, studies have shown that inhibiting DNAJB4 activity can lead to the downregulation of the transcription factor, p53, which is involved in the regulation of DNA replication and repair. This suggests that DNAJB4 may be involved in the regulation of DNA replication and repair, which are critical processes for the development and progression of cancer.

Another study has shown that DNAJB4 may be involved in the regulation of the bile salt export system, which is responsible for the excretion of bile salts from the liver to the intestine. The bile salt export system has been implicated in the development of various liver diseases , including liver cancer. Therefore, inhibiting DNAJB4 activity may be a useful strategy for the treatment of liver diseases associated with bile salt overload or genetic disorders.

In addition to its potential role in the regulation of DNA replication and repair, DNAJB4 has also been shown to be involved in the regulation of cellular signaling pathways that are important for the development of liver cancer. For example, studies have shown that DNAJB4 is involved in the regulation of the PI3K/Akt signaling pathway, which is involved in the regulation of cell survival and proliferation.

DNAJB4 as a biomarker

DNAJB4 has also been used as a biomarker for various liver diseases. For example, studies have shown that the expression of DNAJB4 is significantly increased in the liver tissue of patients with hepatitis C (HCV), a leading cause of liver cancer. This suggests that DNAJB4 may be a useful biomarker for the diagnosis and assessment of liver diseases associated with HCV.

Another study has shown that DNAJB4 expression is significantly increased in the liver tissue of patients with nonalcoholic steatohepatitis (NASH), a type of nonalcoholic liver disease. This suggests that DNAJB4 may be a useful biomarker for the diagnosis and assessment of NASH.

Conclusion

In conclusion, DNAJB4 is a promising

Protein Name: DnaJ Heat Shock Protein Family (Hsp40) Member B4

Functions: Probable chaperone. Stimulates ATP hydrolysis and the folding of unfolded proteins mediated by HSPA1A/B (in vitro) (PubMed:24318877)

The "DNAJB4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DNAJB4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets